RAMM Pharma Corp. (RAMM.CN)

CAD 0.01

(0.0%)

Annual Income Statements

(In CAD)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue 5.06 Million 3.89 Million 4.11 Million 5.44 Million 5.61 Million 8.34 Million
Cost of Revenue 5.96 Million 3.36 Million 4.12 Million 4.16 Million 4.82 Million 6.12 Million
Gross Profit -902.83 Thousand 530.5 Thousand -7641.00 1.28 Million 783.18 Thousand 2.22 Million
Operating Expenses 7.48 Million 8.45 Million 6.63 Million 8.85 Million 2.7 Million 1.89 Million
Selling, General and Administrative Expenses 6.05 Million 7.23 Million 5.69 Million 8.3 Million 2.7 Million 1.89 Million
Research and Development Expenses - - - - - -
Other Expenses - 1.22 Million 940.61 Thousand 556.97 Thousand 143.6 Thousand -
Cost and Expenses 12.15 Million 11.82 Million 10.75 Million 13.02 Million 7.53 Million 8.01 Million
Operating Income -7.08 Million -7.92 Million -7.19 Million -7.57 Million -1.92 Million 332.73 Thousand
Interest Expense 72.08 Thousand 13.29 Thousand 12.83 Thousand 57.75 Thousand 453.71 Thousand 416.05 Thousand
Income Tax Expense 9686.00 8387.00 5556.00 4935.00 5503.00 5649.00
Earnings before Tax -7.71 Million -20.95 Million -7.1 Million -7.42 Million -6.81 Million -678.93 Thousand
Net Income -7.72 Million -20.96 Million -7.1 Million -7.43 Million -6.82 Million -684.58 Thousand
Earnings Per Share Basic -0.06 -0.17 -0.07 -0.07 -0.14 -0.01
Earnings Per Share Diluted -0.06 -0.17 -0.07 -0.07 -0.14 -0.01
Weighted Average Shares Outstanding 121.03 Million 122.77 Million 108.46 Million 100.56 Million 50.41 Million 100.72 Million
Weighted Average Shares Outstanding (Diluted) 121.03 Million 122.77 Million 108.46 Million 100.56 Million 50.41 Million 100.72 Million
Gross Margin -0.18 0.14 -0.00 0.24 0.14 0.27
EBIT Margin -1.24 -1.69 -1.54 -1.25 -0.37 0.04
Profit Margin -1.52 -5.38 -1.73 -1.36 -1.22 -0.08
EBITDA -6.3 Million -19.9 Million -6.35 Million -6.9 Million -6.28 Million -252.64 Thousand
Earnings Before Tax Margin -1.40 -2.03 -1.75 -1.39 -0.34 0.04

Income Statement Charts